Joel Outten
Director, Business Intelligence at Blade Therapeutics - South San Francisco, California, US
Joel Outten's Colleagues at Blade Therapeutics
Daven Mody
Senior Vice President, Global Regulatory Affairs, Quality, and Safety / Project Team Lead
Bassem Elmankabadi
Senior Vice President, Clinical Development (Fibrosis-Oncology and Neurodegenerative)
Joel Outten's Contact Details
(650) 278-4291
San Francisco,California,United States
Blade Therapeutics
Joel Outten's Company Details
Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Fibrosis, a pathologic process in which progressive scarring replaces functional tissue, drives the progression of several debilitating diseases. Uncontrolled, progressive fibrosis leads to organ dysfunction and failure, and potentially death. In the U.S., many millions of Americans are afflicted with a fibrosis-related disease, which may affect organs including the kidney, liver, lungs, skin, and eye. Blade has assembled scientific and leadership teams with unparalleled experience. Our scientific team as well as our Board have extensive expertise in fibrosis and the discovery and development of anti-fibrotic drugs. Blade’s scientific advisory board includes world renowned experts in the pathobiology of fibrotic disease. By targeting novel pathways common to multiple fibrotic disease states, we believe we can build the leading company in anti-fibrotic drug discovery and development.